Decreases in LRP1 levels have been observed in the middle frontal cortexes of patients with AD; higher LRP1 levels significantly correlate with later ages of AD onset, whereas age and LRP1 expression appear to be inversely correlated in unaffected individuals [42]. This evidence concerns the gene LRP1 and Alzheimer disease.